|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
12/23/2008 9:42:31 AM
MONTVALE, N.J., Dec. 23, 2008 (GLOBE NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI), a leader in non-invasive, electrotherapy systems, and RecoverCare, a nationwide leader in the chronic wound care field, today announced that they have signed a definitive agreement granting RecoverCare the exclusive right to distribute, sell and rent certain of Ivivi's targeted pulsed electromagnetic field (tPEMF(tm)) products for the reduction of pain and edema in chronic and acute wounds into long term acute care hospitals (LTACHs) in the United States. RecoverCare was also granted the non-exclusive right to sell and distribute certain of the Company's products for the reduction of pain and edema in chronic and acute wounds in acute care facilities and Veterans Administration long term care facilities in the United States. Ivivi previously announced a non-binding term sheet with RecoverCare on October 24, 2008.
|
|
|
|
|
|
|
|
|
|
|